Neuromodulation therapy redefining migraine relief

Salvia BioElectronics is a clinical-stage medical device company transforming migraine treatment with personalized neuromodulation technology. Its minimally invasive, ultra-thin implant targets key nerves involved in migraine to reduce attack frequency and intensity. Designed for on-demand, user-controlled therapy, Salvia’s solution empowers chronic migraine patients with meaningful, lasting relief. With FDA Breakthrough Device designation and global clinical trials underway, Salvia is advancing towards commercialization to reach millions suffering from disabling headaches.

‍